The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women.
Abstract
BACKGROUND: The relative absence of coronary atherosclerosis in premenopausal women has been established. Estrogen is presumed to play a role in the protection of coronary arteries from atherosclerosis, and part of this protective effect appears to be mediated by amelioration of serum lipid profiles. However, all of the atheroprotective effect of estrogen is not explained by alteration of serum lipids. In this study, we attempt to identify evidence of estrogen receptors in coronary artery specimens of female patients and in human vascular smooth muscle cells. METHODS AND RESULTS: Postmortem coronary artery specimens were obtained from premenopausal (n = 18) and postmenopausal (n = 22) women who died with significant coronary artery disease (n = 19) and from noncardiac causes with normal coronary arteries (n = 21). Sections were examined for evidence of estrogen receptor expression using a monoclonal antibody stain. Radioligand binding assays for estrogen receptors were performed on human vascular smooth muscle cells in culture, and gel retardation assays were performed to confirm the presence of functional estrogen receptors. Estrogen receptor expression was identified by immunostaining in a total of 21 coronary arteries, with the majority of normal arteries (15 positive of 21 total, P = .0117) demonstrating evidence of estrogen receptor expression. Conversely, a minority (6 of 19, P = NS) of atherosclerotic arteries were positive for estrogen receptor expression. Furthermore, the relation between estrogen receptor expression and absence of coronary atherosclerosis was most evident in premenopausal subjects, with 10 of 12 normal arteries in this group demonstrating evidence of estrogen receptors, whereas only 1 of 6 atherosclerotic coronary arteries was positive (P = .0062). Radioligand binding assays confirmed the presence of estrogen receptors at significant concentrations in intact human vascular smooth muscle cells. Gel retardation assays also documented the presence of functional estrogen receptors in extracts from human vascular smooth muscle cells. CONCLUSIONS: This investigation provides evidence of estrogen receptors in smooth muscle cells from human coronary arteries. The demonstrated relation between the presence of the receptors and the absence of atherosclerosis in premenopausal women suggests that these receptors may play a functional role in coronary atheroprotection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS
Scatchard, G. (1949) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1949.tb27297.x · Cited by 19,778
Bush, T. L., Barrett-Connor, E., Cowan, L. D., Criqui, M. H., Wallace, R. B., Suchindran, C. M., Tyroler, H. A., & Rifkind, B. M. (1987) · Circulation · doi:10.1161/01.cir.75.6.1102 · Cited by 1,346
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
Menopause and Risk Factors for Coronary Heart Disease
Matthews, K. A., Meilahn, E., Kuller, L. H., Kelsey, S. F., Caggiula, A. W., & Wing, R. R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198909073211004 · Cited by 1,040
Nabulsi, A. A., Folsom, A. R., White, A., Patsch, W., Heiss, G., Wu, K. K., & Szklo, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199304153281501 · Cited by 906
Horwitz, K. B., Costlow, M. E., & McGuire, W. L. (1975) · Steroids · doi:10.1016/0039-128x(75)90110-5 · Cited by 453
Short-term administration of estrogen and vascular responce of atherosclerotic coronary arteries
Williams, J. K., Adams, M. R., Herrington, D. M., & Clarkson, T. B. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90116-5 · Cited by 357
Postmenopausal use of estrogen and occlusion of coronary arteries
Gruchow, H. W., Anderson, A. J., Barboriak, J. J., & Sobocinski, K. A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90063-4 · Cited by 327
TIKKANEN, M. J., NIKKILÄ, E. A., KUUSI, T., & SIPINEN, S. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-6-1113 · Cited by 273
Cited by
The Protective Effects of Estrogen on the Cardiovascular System
Mendelsohn, M. E., & Karas, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906103402306 · Cited by 3,103
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045
Estrogen receptors and human disease
Deroo, B. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27987 · Cited by 1,320
Pharmacology of estrogens and progestogens: influence of different routes of administration
Kuhl, H. (2005) · Climacteric · doi:10.1080/13697130500148875 · Cited by 835
Vascular effects of early versus late postmenopausal treatment with estradiol
Hodis, H. N., Mack, W. J., Henderson, V. W., Shoupe, D., Budoff, M. J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1505241 · Cited by 779
Mechanistic Pathways of Sex Differences in Cardiovascular Disease
Regitz-Zagrosek, V., & Kararigas, G. (2017) · Physiological Reviews · doi:10.1152/physrev.00021.2015 · Cited by 732
The vascular protective effects of estrogen
Farhat, M. Y., Lavigne, M. C., & Ramwell, P. W. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621060 · Cited by 639
Hormone therapy for preventing cardiovascular disease in post-menopausal women
Boardman, H. M., Hartley, L., Eisinga, A., Main, C., Roqué i Figuls, M., Bonfill Cosp, X., Gabriel Sanchez, R., & Knight, B. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002229.pub4 · Cited by 612
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice
Iafrati, M. D., Karas, R. H., Aronovitz, M., Kim, S., Sullivan, T. R., Lubahn, D. B., O'Donnell, T. F., Korach, K. S., & Mendelsohn, M. E. (1997) · Nature Medicine · doi:10.1038/nm0597-545 · Cited by 486
Post, W. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00153-4 · Cited by 482
JCS Joint Working Group (2014) · Circulation Journal · doi:10.1253/circj.cj-66-0098 · Cited by 459
Vaccarino, V., Abramson, J. L., Veledar, E., & Weintraub, W. S. (2002) · Circulation · doi:10.1161/hc1002.105133 · Cited by 395
Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women
Hodis, H. N., Mack, W. J., Azen, S. P., Lobo, R. A., Shoupe, D., Mahrer, P. R., Faxon, D. P., Cashin-Hemphill, L., Sanmarco, M. E., French, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030830 · Cited by 386
Cardiac myocytes and fibroblasts contain functional estrogen receptors1
Grohé, C., Kahlert, S., Löbbert, K., Stimpel, M., Karas, R. H., Vetter, H., & Neyses, L. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01179-4 · Cited by 382
Gender differences in the cardiovascular effect of sex hormones
Vitale, C., Mendelsohn, M. E., & Rosano, G. M. C. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.105 · Cited by 368
Sex Differences in 2-Year Mortality after Hospital Discharge for Myocardial Infarction
Vaccarino, V., Krumholz, H. M., Yarzebski, J., Gore, J. M., & Goldberg, R. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-3-200102060-00007 · Cited by 361
Estrogen and Angiogenesis: A Review
Losordo, D. W., & Isner, J. M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.21.1.6 · Cited by 352
Self-citationVenkov, C. D., Rankin, A. B., & Vaughan, D. E. (1996) · Circulation · doi:10.1161/01.cir.94.4.727 · Cited by 329
The roles of gender, the menopause and hormone replacement on cardiovascular function
Hayward, C. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00005-5 · Cited by 315
Vascular Compliance and Cardiovascular Disease A Risk Factor or a Marker?
Glasser, S. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00311-7 · Cited by 308
CpG-Island Methylation in Aging and Cancer
Issa, J.-P. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_7 · Cited by 300
Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques
Honoré, E. K., Koudy Williams, J., Anthony, M. S., & Clarkson, T. B. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81872-9 · Cited by 299
Increased Expression of Estrogen Receptor-β mRNA in Male Blood Vessels After Vascular Injury
Lindner, V., Kim, S. K., Karas, R. H., Kuiper, G. G. J. M., Gustafsson, J.-A., & Mendelsohn, M. E. (1998) · Circulation Research · doi:10.1161/01.res.83.2.224 · Cited by 294
Spyridopoulos, I., Sullivan, A. B., Kearney, M., Isner, J. M., & Losordo, D. W. (1997) · Circulation · doi:10.1161/01.cir.95.6.1505 · Cited by 285
Self-citationDiabetes Mellitus and Cardiovascular Disease in Women
Sowers, J. R. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.617 · Cited by 278
Hormonal Therapy Increases Arterial Compliance in Postmenopausal Women
Rajkumar, C., Kingwell, B. A., Cameron, J. D., Waddell, T., Mehra, R., Christophidis, N., Komesaroff, P. A., McGrath, B., Jennings, G. L., Sudhir, K., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00191-5 · Cited by 276
Migraine in women: the role of hormones and their impact on vascular diseases
Sacco, S., Ricci, S., Degan, D., & Carolei, A. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0424-y · Cited by 272
Rubanyi, G. M., Freay, A. D., Kauser, K., Sukovich, D., Burton, G., Lubahn, D. B., Couse, J. F., Curtis, S. W., & Korach, K. S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119426 · Cited by 270
Osteoporosis and Coronary Atherosclerosis in Asymptomatic Postmenopausal Women
Barengolts, E. I., Berman, M., Kukreja, S. C., Kouznetsova, T., Lin, C., & Chomka, E. V. (1998) · Calcified Tissue International · doi:10.1007/s002239900419 · Cited by 270
Lu, Q., Pallas, D. C., Surks, H. K., Baur, W. E., Mendelsohn, M. E., & Karas, R. H. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407492101 · Cited by 266
Rosselli, M., Imthurn, B., Keller, P. J., Jackson, E. K., & Dubey, R. K. (1995) · Hypertension · doi:10.1161/01.hyp.25.4.848 · Cited by 265
Influence of Sex on Arterial Hemodynamics and Blood Pressure: Role of Body Height
London, G. M., Guerin, A. P., Pannier, B., Marchais, S. J., & Stimpel, M. (1995) · Hypertension · doi:10.1161/01.hyp.26.3.514 · Cited by 258
Estrogen Reduces Myointimal Proliferation After Balloon Injury of Rat Carotid Artery
Chen, S.-J., Li, H., Durand, J., Oparil, S., & Chen, Y.-F. (1996) · Circulation · doi:10.1161/01.cir.93.3.577 · Cited by 257
Sex steroids as inflammatory regulators
Gilliver, S. C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.015 · Cited by 198
Gormsen, L. C., Høst, C., Hjerrild, B. E., Pedersen, S. B., Nielsen, S., Christiansen, J. S., & Gravholt, C. H. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0422 · Cited by 42
(2015) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 7
Metadata
- Authors
- Losordo, D. W., Kearney, M., Kim, E. A., Jekanowski, J., & Isner, J. M.
- Venue
- Circulation
- Published
- 1994-04
- Volume
- 89
- Issue
- 4
- Pages
- 1501-1510
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2141991871
- Cited by
- 496
- References
- 25
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.